Edwards Lifesciences (EW) vs Materion (MTRN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Materion (MTRN) has outperformed Edwards Lifesciences (EW) over the past year, gaining 133.1% versus a gain of 11.8%. Over five years, MTRN leads with a +303.2% price change compared with -23.5% for EW. Edwards Lifesciences is the larger company by market cap ($49.44 billion vs $6.06 billion), about 8.2 times the size.
On valuation, Edwards Lifesciences trades at a lower forward P/E (25.4x vs 34.5x for Materion). Materion pays a dividend yielding 0.19%, while Edwards Lifesciences does not currently pay one. Edwards Lifesciences converts more of its revenue into profit, with a net margin of 17.7% versus 4.2%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | EW | MTRN |
|---|---|---|
| Share price | $85.78 | $290.72 |
| Market cap | $49.44B | $6.06B |
| 1-day change | -0.81% | -6.87% |
| YTD return | +0.62% | +133.85% |
| 1-year return | +11.81% | +133.14% |
| 5-year return | -23.52% | +303.16% |
| P/E ratio (TTM) | 51.06 | 67.77 |
| Forward P/E | 25.40 | 34.47 |
| EPS (TTM) | $1.68 | $4.29 |
| Dividend yield | 0.00% | 0.19% |
| Annual dividend | $0.00 | $0.565 |
| Revenue (latest FY) | $6.07B | $1.79B |
| Revenue growth (YoY) | +11.55% | +6.04% |
| Net income (latest FY) | $1.07B | $74.82M |
| Gross margin | 78.01% | 17.27% |
| Operating margin | 20.84% | 6.15% |
| Net margin | 17.69% | 4.19% |
| 52-week high | $96.29 | $324.99 |
| 52-week low | $72.30 | $109.61 |
| Distance from 52-week high | -10.91% | -10.54% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +18.86% | +4.48% |
| Average volume | 3.82M | 315.36K |
| Shares outstanding | 576.40M | 20.83M |
| Employees | 16,000 | 3,000 |
| Sector | Health Care | Industrials |
| Industry | Industrial Specialties | Industrial Specialties |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Edwards Lifesciences is about 8.2 times larger than Materion by market value ($49.44B vs $6.06B).
- MTRN has outperformed EW by 121.3 percentage points over the past year.
- Materion trades at a higher earnings multiple (67.8x vs 51.1x trailing P/E).
- Edwards Lifesciences is more profitable, keeping 17.7 cents of every revenue dollar as net income versus 4.2 cents for Materion.
- Edwards Lifesciences grew revenue faster in its latest fiscal year (+11.55% vs +6.04%).
- The two companies sit in different sectors: Edwards Lifesciences in Health Care and Materion in Industrials.
About Edwards Lifesciences
EW stock →Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands.
Health Care · Industrial Specialties · 16,000 employees
About Materion
MTRN stock →Materion Corporation, together with its subsidiaries, produces advanced engineered materials in the United States, Asia, Europe, and internationally. The company operates in four segments: Performance Materials, Electronic Materials, Precision Optics, and Other.
Industrials · Industrial Specialties · 3,000 employees
EW vs MTRN FAQ
Which is bigger, Edwards Lifesciences or Materion?
Edwards Lifesciences (EW) is larger, with a market capitalization of $49.44B compared with $6.06B for Materion (MTRN).
Which stock has performed better over the past year, EW or MTRN?
MTRN returned +133.14% over the past 12 months, compared with +11.81% for EW (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, EW or MTRN?
EW has the lower trailing P/E at 51.1, versus 67.8 for MTRN. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Edwards Lifesciences or Materion?
Materion pays a dividend yielding 0.19%, while Edwards Lifesciences does not currently pay a regular dividend.
Are Edwards Lifesciences and Materion in the same industry?
Yes. Both are classified in the Industrial Specialties industry within the Health Care sector.